332 related articles for article (PubMed ID: 21901858)
21. Defining lower airway bacterial infection in children with chronic endobronchial disorders.
Hare KM; Pizzutto SJ; Chang AB; Smith-Vaughan HC; McCallum GB; Beissbarth J; Versteegh L; Grimwood K
Pediatr Pulmonol; 2018 Feb; 53(2):224-232. PubMed ID: 29265639
[TBL] [Abstract][Full Text] [Related]
22. PPARγ is reduced in the airways of non-CF bronchiectasis subjects and is inversely correlated with the presence of Pseudomonas aeruginosa.
Burr LD; Rogers GB; Chen AC; Taylor SL; Bowler SD; Keating RL; Martin ML; Hasnain SZ; McGuckin MA
PLoS One; 2018; 13(8):e0202296. PubMed ID: 30114278
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of a multiplex PCR for bacterial pathogens applied to bronchoalveolar lavage.
Strålin K; Korsgaard J; Olcén P
Eur Respir J; 2006 Sep; 28(3):568-75. PubMed ID: 16737990
[TBL] [Abstract][Full Text] [Related]
24. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
[TBL] [Abstract][Full Text] [Related]
25. Do New Zealand children with non-cystic fibrosis bronchiectasis show disease progression?
Munro KA; Reed PW; Joyce H; Perry D; Twiss J; Byrnes CA; Edwards EA
Pediatr Pulmonol; 2011 Feb; 46(2):131-8. PubMed ID: 20717910
[TBL] [Abstract][Full Text] [Related]
26. Identifying peroxidases and their oxidants in the early pathology of cystic fibrosis.
Thomson E; Brennan S; Senthilmohan R; Gangell CL; Chapman AL; Sly PD; Kettle AJ; ; Balding E; Berry LJ; Carlin JB; Carzino R; de Klerk N; Douglas T; Foo C; Garratt LW; Hall GL; Harrison J; Kicic A; Laing IA; Logie KM; Massie J; Mott LS; Murray C; Parsons F; Pillarisetti N; Poreddy SR; Ranganathan SC; Robertson CF; Robins-Browne R; Robinson PJ; Skoric B; Stick SM; Sutanto EN; Williamson E
Free Radic Biol Med; 2010 Nov; 49(9):1354-60. PubMed ID: 20647044
[TBL] [Abstract][Full Text] [Related]
27. Bacterial colonisation of lower airways in health and chronic lung disease.
Weinreich UM; Korsgaard J
Clin Respir J; 2008 Apr; 2(2):116-22. PubMed ID: 20298316
[TBL] [Abstract][Full Text] [Related]
28. Nontuberculous mycobacterial infection in young children with cystic fibrosis.
Esther CR; Henry MM; Molina PL; Leigh MW
Pediatr Pulmonol; 2005 Jul; 40(1):39-44. PubMed ID: 15858802
[TBL] [Abstract][Full Text] [Related]
29. Respiratory viruses are associated with common respiratory pathogens in cystic fibrosis.
Esther CR; Lin FC; Kerr A; Miller MB; Gilligan PH
Pediatr Pulmonol; 2014 Sep; 49(9):926-31. PubMed ID: 24167159
[TBL] [Abstract][Full Text] [Related]
30. Bacterial bronchitis and bronchiectasis in human immunodeficiency virus infection.
Verghese A; al-Samman M; Nabhan D; Naylor AD; Rivera M
Arch Intern Med; 1994 Sep; 154(18):2086-91. PubMed ID: 8092913
[TBL] [Abstract][Full Text] [Related]
31. Do combined upper airway cultures identify lower airway infections in children with chronic cough?
Hare KM; Chang AB; Smith-Vaughan HC; Bauert PA; Spain B; Beissbarth J; Grimwood K
Pediatr Pulmonol; 2019 Jun; 54(6):907-913. PubMed ID: 31006971
[TBL] [Abstract][Full Text] [Related]
32. Non-cystic-fibrosis bronchiectasis in children: a persisting problem in developing countries.
Karadag B; Karakoc F; Ersu R; Kut A; Bakac S; Dagli E
Respiration; 2005; 72(3):233-8. PubMed ID: 15942290
[TBL] [Abstract][Full Text] [Related]
33. Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis.
Tramper-Stranders GA; Wolfs TF; van Haren Noman S; van Aalderen WM; Nagelkerke AF; Nuijsink M; Kimpen JL; van der Ent CK
Thorax; 2010 Oct; 65(10):915-20. PubMed ID: 20729233
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for bronchiectasis in children with cystic fibrosis.
Sly PD; Gangell CL; Chen L; Ware RS; Ranganathan S; Mott LS; Murray CP; Stick SM;
N Engl J Med; 2013 May; 368(21):1963-70. PubMed ID: 23692169
[TBL] [Abstract][Full Text] [Related]
35. Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis.
Sagel SD; Gibson RL; Emerson J; McNamara S; Burns JL; Wagener JS; Ramsey BW; ;
J Pediatr; 2009 Feb; 154(2):183-8. PubMed ID: 18822427
[TBL] [Abstract][Full Text] [Related]
36. Geographical differences in first acquisition of Pseudomonas aeruginosa in cystic fibrosis.
Ranganathan SC; Skoric B; Ramsay KA; Carzino R; Gibson AM; Hart E; Harrison J; Bell SC; Kidd TJ;
Ann Am Thorac Soc; 2013 Apr; 10(2):108-14. PubMed ID: 23607838
[TBL] [Abstract][Full Text] [Related]
37. Value of serology in predicting Pseudomonas aeruginosa infection in young children with cystic fibrosis.
Douglas TA; Brennan S; Berry L; Winfield K; Wainwright CE; Grimwood K; Stick SM; Sly PD;
Thorax; 2010 Nov; 65(11):985-90. PubMed ID: 20889526
[TBL] [Abstract][Full Text] [Related]
38. Prospective study of fever after bronchoalveolar lavage in children.
Hemmers T; Nüsslein T; Teig N; Rieger C; Stephan V
Klin Padiatr; 2006; 218(2):74-8. PubMed ID: 16506107
[TBL] [Abstract][Full Text] [Related]
39. [Respiratory pathogen spectrum in pulmonary exacerbation of bronchiectasis in adults and its association with disease severity].
Gao YH; Guan WJ; Zhu YN; Chen RC; Zhang GJ
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Apr; 42(4):254-261. PubMed ID: 30955282
[No Abstract] [Full Text] [Related]
40. Immunity and bacterial colonisation in bronchiectasis.
Whitters D; Stockley R
Thorax; 2012 Nov; 67(11):1006-13. PubMed ID: 21933944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
